Response to first-line platinum chemotherapy in microsatellite instability high (MSI-H) metastatic endometrial carcinoma

被引：0
|
作者：
Colomba, E. [1 ]
Alexandre, J. [2 ]
Le Teuff, G. [3 ]
Coupez, D. [4 ]
Genestie, C. [5 ]
Ray-Coquard, I. L. [6 ]
Brachet, P. E. [7 ]
Sajous, C. [8 ]
De Percin, S. [9 ]
Fabbro, M. [10 ]
Delanoy, N. [11 ]
Joly, F. [12 ]
Pautier, P. [13 ]
Frenel, J-S. [14 ]
Leary, A. [15 ]
机构：
[1] Inst Gustave Roussy, Med Oncol Dept, Villejuif, France
[2] Hop Cochin Site Port Royal, AP HP, Oncol, Paris, France
[3] Inst Gustave Roussy, Dept Biostatist, Villejuif, France
[4] CHU Nantes Hotel Dieu, Oncol, Nantes, France
[5] Inst Gustave Roussy, Pathol, Villejuif, France
[6] Ctr Leon Berard, Dept Med Oncol, Lyon, France
[7] Ctr Francois Baclesse, Med Oncol Dept, Caen, France
[8] Inst Cancerol Hosp Civils Lyon IC HCL, Med Oncol Dept, Lyon, France
[9] Hop Univ Paris Ctr Med Oncol, Hop Cochin, Paris, France
[10] Inst Canc Montpellier, Dept Med Oncol, Montpellier, France
[11] Hop European George Pompidou, Dept Med Oncol, Paris, France
[12] Ctr Francois Baclesse, Med Oncol, Caen, France
[13] Inst Gustave Roussy, Dept Med, Villejuif, France
[14] ICO Inst Cancerol IOuest Rene Gauducheau, Dept Med Oncol, Saint Herblain, France
[15] Inst Gustave Roussy, Dept Med Oncol, Villejuif, France
来源：
ANNALS OF ONCOLOGY | 2021年 / 32卷
关键词：
D O I：
10.1016/j.annonc.2021.08.1243
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
801P
引用
收藏
页码：S763 / S763
页数：1
相关论文
共 50 条
  • [1] Response to first line platinum-based chemotherapy in mismatch repair deficient (MMRd)/microsatellite instability high (MSI-high) endometrial carcinoma
    Colomba, Emeline
    Alexandre, Jerome
    Le Teuff, Gwenael
    Genestie, Catherine
    Coupez, Dahna
    Coquard, Isabelle Ray
    Brachet, Pierre Emmanuel
    de Percin, Sixtine
    Sajous, Christophe
    Fabbro, Michel
    Delanoy, Nicolas
    Joly, Florence
    Frenel, Jean Sebastien
    Pautier, Patricia
    Leary, Alexandra
    GYNECOLOGIC ONCOLOGY, 2023, 169 : 78 - 84
  • [2] Management of Microsatellite Instability High (MSI-H) Gastroesophageal Adenocarcinoma
    Zhou, Katherine I.
    Hanks, Brent A.
    Strickler, John H.
    JOURNAL OF GASTROINTESTINAL CANCER, 2024, 55 (02) : 483 - 496
  • [3] Response to nivolumab and ipilimumab in microsatellite instability-high (MSI-H) cervical carcinoma with acquired resistance to pembrolizumab
    Gim, Gahyun
    Cho, Sukjoo
    Lee, Dongyup
    Park, Jonghanne
    Kim, Leeseul
    Choi, Horyun
    Kang, Cyra Y.
    Vagia, Elena
    Viveiros, Pedro
    Chae, Young Kwang
    CANCER RESEARCH, 2020, 80 (16)
  • [4] Microsatellite instability (MSI-H) in metastatic urothelial carcinoma (mUC): A biomarker of divergent responses to systemic therapy
    Sarfaty, Michal
    Teo, Min Yuen
    Al-Ahmadie, Hikmat
    Funt, Samuel Aaron
    Lee, Chung-Han
    Aggen, David Henry
    Solit, David B.
    Ratna, Neha
    Regazzi, Ashley Marie
    Hechtman, Jaclyn Frances
    Zehir, Ahmet
    Rosenberg, Jonathan E.
    Bajorin, Dean F.
    Iyer, Gopa
    JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (06)
  • [5] New first-line therapy for dMMR/MSI-H CRC
    Romero, Diana
    NATURE REVIEWS CLINICAL ONCOLOGY, 2021, 18 (02) : 63 - 63
  • [6] New first-line therapy for dMMR/MSI-H CRC
    Diana Romero
    Nature Reviews Clinical Oncology, 2021, 18 : 63 - 63
  • [7] SURVIVAL OUTCOMES IN METASTATIC COLORECTAL CANCER (CRC) WITH HIGH-LEVEL MICROSATELLITE INSTABILITY (MSI-H)
    Overman, M. J.
    Kopetz, S.
    Wong, S.
    Tie, J.
    Kosmider, S.
    Jacob, A.
    Vilar, E.
    Gibbs, P.
    Desai, J.
    Tran, B.
    ANNALS OF ONCOLOGY, 2012, 23 : 220 - 221
  • [8] Dabrafenib and trametinib activity in a patient with BRAF V600E mutated and microsatellite instability high (MSI-H) metastatic endometrial cancer
    Moschetta, Michele
    Mak, Gabriel
    Hauser, Joana
    Davies, Catriona
    Uccello, Mario
    Arkenau, Hendrik-Tobias
    EXPERIMENTAL HEMATOLOGY & ONCOLOGY, 2017, 5
  • [9] FDA Approval Summary: Pembrolizumab for the First-line Treatment of Patients with MSI-H/dMMR Advanced Unresectable or Metastatic Colorectal Carcinoma
    Casak, Sandra J.
    Marcus, Leigh
    Fashoyin-Aje, Lola
    Mushti, Sirisha L.
    Cheng, Joyce
    Shen, Yuan-Li
    Pierce, William F.
    Her, Leah
    Goldberg, Kirsten B.
    Theoret, Marc R.
    Kluetz, Paul G.
    Pazdur, Richard
    Lemery, Steven J.
    CLINICAL CANCER RESEARCH, 2021, 27 (17) : 4680 - 4684
  • [10] Dabrafenib and trametinib activity in a patient with BRAF V600E mutated and microsatellite instability high (MSI-H) metastatic endometrial cancer
    Michele Moschetta
    Gabriel Mak
    Joana Hauser
    Catriona Davies
    Mario Uccello
    Hendrik-Tobias Arkenau
    Experimental Hematology & Oncology, 6
12345